Cash Flow Statement
Growth Metrics

SRx Health Solutions (SRXH) Cash & Current Investments (2016 - 2025)

SRx Health Solutions' Cash & Current Investments history spans 13 years, with the latest figure at $1.3 million for Q3 2025.

  • For Q3 2025, Cash & Current Investments rose 1134.91% year-over-year to $1.3 million; the TTM value through Sep 2025 reached $1.3 million, up 1134.91%, while the annual FY2025 figure was $1.3 million, N/A changed from the prior year.
  • Cash & Current Investments reached $1.3 million in Q3 2025 per SRXH's latest filing, up from $912000.0 in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $33.3 million in Q3 2021 to a low of $106000.0 in Q3 2024.
  • Average Cash & Current Investments over 5 years is $9.1 million, with a median of $3.9 million recorded in 2024.
  • Peak YoY movement for Cash & Current Investments: soared 1498.32% in 2021, then crashed 97.21% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $28.9 million in 2021, then plummeted by 45.5% to $15.8 million in 2022, then plummeted by 71.76% to $4.5 million in 2023, then crashed by 31.18% to $3.1 million in 2024, then crashed by 57.31% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Cash & Current Investments are $1.3 million (Q3 2025), $912000.0 (Q2 2025), and $1.1 million (Q1 2025).